{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:40:16Z","timestamp":1778697616902,"version":"3.51.4"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/md.0000000000002973","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T13:04:29Z","timestamp":1461330269000},"page":"e2973","source":"Crossref","is-referenced-by-count":24,"title":["Haploidentical Transplantation Without In Vitro T-Cell Depletion Results in Outcomes Equivalent to Those of Contemporaneous Matched Sibling and Unrelated Donor Transplantation for Acute Leukemia"],"prefix":"10.1097","volume":"95","author":[{"given":"Sijian","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiping","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianli","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongsheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Fa","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-15-20210226","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbmt.2008.06.006","article-title":"Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program","volume":"14","author":"Karanes","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"R2-15-20210226","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1200\/JCO.2007.15.5184","article-title":"Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group","volume":"26","author":"Schetelig","year":"2008","journal-title":"J Clin Oncol"},{"key":"R3-15-20210226","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1200\/JCO.2006.08.0952","article-title":"Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10\/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy","volume":"24","author":"Yakoub-Agha","year":"2006","journal-title":"J Clin Oncol"},{"key":"R4-15-20210226","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bcmd.2004.08.008","article-title":"Fourth International Workshop on Haploidentical Transplants, Naples, Italy, July 8\u201310, 2004","volume":"33","author":"Aversa","year":"2004","journal-title":"Blood Cells Mol Dis"},{"key":"R5-15-20210226","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","article-title":"Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse","volume":"23","author":"Aversa","year":"2005","journal-title":"J Clin Oncol"},{"key":"R6-15-20210226","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1756-8722-5-10","article-title":"Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go","volume":"5","author":"Lv","year":"2012","journal-title":"J Hematol Oncol"},{"key":"R7-15-20210226","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"R8-15-20210226","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.2012.44.3523","article-title":"T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation","volume":"31","author":"Bashey","year":"2013","journal-title":"J Clin Oncol"},{"key":"R9-15-20210226","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1182\/blood-2014-04-571570","article-title":"T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT","volume":"124","author":"Luo","year":"2014","journal-title":"Blood"},{"key":"R10-15-20210226","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/blood-2002-09-2866","article-title":"Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors","volume":"102","author":"Ottinger","year":"2003","journal-title":"Blood"},{"key":"R11-15-20210226","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1182\/blood-2003-02-0430","article-title":"Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991\u20132000)","volume":"102","author":"Kanda","year":"2003","journal-title":"Blood"},{"key":"R12-15-20210226","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1182\/blood.V99.3.806","article-title":"Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts","volume":"99","author":"Drobyski","year":"2002","journal-title":"Blood"},{"key":"R13-15-20210226","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2005-05-2146","article-title":"Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched\/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation","volume":"107","author":"Lu","year":"2006","journal-title":"Blood"},{"key":"R14-15-20210226","first-page":"687","article-title":"Allo-HSCT for acute leukemia of ambiguous lineage in adults: the comparison between standard conditioning and intensified conditioning regimens.","volume":"679-","author":"Liu","year":"2013","journal-title":"Ann Hematol"},{"key":"R15-15-20210226","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1756-8722-5-46","article-title":"Effects of intensified conditioning on Epstein\u2013Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies","volume":"5","author":"Xuan","year":"2012","journal-title":"J Hematol Oncol"},{"key":"R16-15-20210226","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bcmd.2010.02.017","article-title":"Peripheral blood stem cell transplantation compared with bone marrow transplantation from unrelated donors in patients with leukemia: a single institutional experience","volume":"45","author":"Liu","year":"2010","journal-title":"Blood Cells Mol Dis"},{"key":"R17-15-20210226","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"R18-15-20210226","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.blre.2005.01.007","article-title":"Chronic graft-versus-host disease","volume":"20","author":"Horwitz","year":"2006","journal-title":"Blood Rev"},{"key":"R19-15-20210226","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.bbmt.2010.03.024","article-title":"HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk category","volume":"16","author":"Woolfrey","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"R20-15-20210226","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.beha.2012.10.012","article-title":"Does matched unrelated donor transplantation have the same outcome as matched sibling transplantation in unselected patients?","volume":"25","author":"Horowitz","year":"2012","journal-title":"Best Pract Res Clin Haematol"},{"key":"R21-15-20210226","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.bbmt.2010.12.702","article-title":"Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation","volume":"17","author":"Ho","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"R22-15-20210226","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1182\/blood-2011-09-381699","article-title":"Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia","volume":"119","author":"Saber","year":"2012","journal-title":"Blood"},{"key":"R23-15-20210226","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1158\/1078-0432.CCR-09-0691","article-title":"Partially matched related donor transplantation can achieve outcomes comparable with unrelated donor transplantation for patients with hematologic malignancies","volume":"15","author":"Xiao-Jun","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R24-15-20210226","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/cncr.27761","article-title":"Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center","volume":"119","author":"Wang","year":"2013","journal-title":"Cancer"},{"key":"R25-15-20210226","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJM198509263131301","article-title":"Marrow transplantation from related donors other than HLA-identical siblings","volume":"313","author":"Beatty","year":"1985","journal-title":"N Engl J Med"},{"key":"R26-15-20210226","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1200\/JCO.1997.15.5.1767","article-title":"Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings","volume":"15","author":"Szydlo","year":"1997","journal-title":"J Clin Oncol"},{"key":"R27-15-20210226","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation","volume":"117","author":"Di Ianni","year":"2011","journal-title":"Blood"},{"key":"R28-15-20210226","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/sj.bmt.1705966","article-title":"Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States","volume":"41","author":"Aversa","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"R29-15-20210226","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1182\/blood-2014-03-564401","article-title":"HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse","volume":"124","author":"Martelli","year":"2014","journal-title":"Blood"},{"key":"R30-15-20210226","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/bbmt.2002.v8.pm12171484","article-title":"Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide","volume":"8","author":"O\u2019Donnell","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"R31-15-20210226","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.bbmt.2012.06.019","article-title":"Haploidentical transplantation using T cell replete peripheral blood stem cells and myeloablative conditioning in patients with high-risk hematologic malignancies who lack conventional donors is well tolerated and produces excellent relapse-free survival: results of a prospective phase II trial","volume":"18","author":"Solomon","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"R32-15-20210226","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.bbmt.2008.08.014","article-title":"Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma","volume":"14","author":"Burroughs","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"R33-15-20210226","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1182\/blood-2008-07-163212","article-title":"The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical sibings for hematopoietic stem cell transplantation","volume":"113","author":"Ringd\u00e9n","year":"2009","journal-title":"Blood"},{"key":"R34-15-20210226","first-page":"830","article-title":"Superior graft-versus-leukemia effect associated with transplantation of haploidentical compared with HLA-identical sibling donor grafts for high-risk acute leukemia: an historic comparison.","volume":"821-","author":"Wang","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"R35-15-20210226","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.bbmt.2012.07.003","article-title":"Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation","volume":"18","author":"Ciurea","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"R36-15-20210226","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood.V98.4.972","article-title":"Epstein\u2013Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell\u2014depleted SCT","volume":"98","author":"van Esser","year":"2001","journal-title":"Blood"},{"key":"R37-15-20210226","doi-asserted-by":"crossref","first-page":"A8","DOI":"10.1186\/1756-8722-5-S1-A8","article-title":"Epstein\u2013Barr virus-associated diseases in allogeneic hematopoietic stem cell transplantation","volume":"5","author":"Wu","year":"2012","journal-title":"J Hematol Oncol"},{"key":"R38-15-20210226","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1182\/blood-2011-09-380386","article-title":"Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation","volume":"119","author":"Yan","year":"2012","journal-title":"Blood"},{"key":"R39-15-20210226","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s10875-008-9193-4","article-title":"Modified donor lymphocyte infusion (DLI) for the prophylaxis of leukemia relapse after hematopoietic stem cell transplantation in patients with advanced leukemia\u2014feasibility and safety study","volume":"28","author":"Huang","year":"2008","journal-title":"J Clin Immunol"},{"key":"R40-15-20210226","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1399-0012.2012.01626.x","article-title":"Prevention of relapse using DLI can increase survival following HLA-identical transplantation in patients with advanced-stage acute leukemia: a multicenter study","volume":"26","author":"Wang","year":"2012","journal-title":"Clin Transplant"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000002973","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:19:06Z","timestamp":1620958746000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201603150-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000002973","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}